Biome Australia Limited (BIO) Earnings Call Transcripts

Biome Australia Limited's Latest Earnings Call - June 4, 2026

In the first half of FY '26, Biome Australia Limited (BIO:AU) reported a record revenue of $12.4 million, reflecting a 40% increase year-over-year. Adjusted EBITDA reached $1.47 million, marking the eighth consecutive quarter of growth, while net profit surged 172% to $1.18 million. Management announced plans to enhance gross margins to over 65% by FY '27 through onshoring manufacturing, which could significantly improve cash flow and operational efficiency, positioning the company for continued growth in the competitive probiotic market.

Reported metrics

Guidance from management

Management expects to achieve gross margins exceeding 65% by FY '27 due to onshoring manufacturing, which will also improve cash flow and operational efficiency.

What management said

Thanks. Yes. Super exciting. Obviously, I'll just speak to some of the key points in what we've flagged obviously in our announcement earlier this week is the gross margin uplift. So we do expect that in the next 18 months as we scale and transition onshore that we will be able to achieve 65% plus gross profit margin, which is obviously a key financial metric, and we do...

That's something we, together did an analysis on only a couple of months ago, just with the growth in the business with supporting that growth for the future, the amount of inventory that we're starting to see was creeping up to the point where I think at 1 point, there was more than $2 million sitting at sea in that time period, which is aging. It creates a strategic challenge for us as well with our customers. Some...

What analysts pressed on

Analysts expressed concerns about the lack of Q3 revenue reporting and its potential impact on transparency. There were also questions regarding the company's strategy for entering the Chinese market amidst regulatory challenges.

Main topics on the call

• Record Revenue Growth — Biome reported a record revenue of $12.4 million for H1 FY '26, up 40% from the previous year. CEO Blair Norfolk stated, "we're on for another record year in FY '26," indicating strong momentum.
• Improved Profitability Metrics — The company achieved a net profit of $1.18 million, up 172% year-over-year. CFO Lauren Dwyer highlighted, "our adjusted EBITDA...was $1.47 million," showcasing consistent profitability improvements.
• Onshoring Manufacturing Strategy — Management announced plans to onshore manufacturing, which is expected to enhance gross margins to over 65% by FY '27. Norfolk emphasized this as a "massive commercial opportunity for Biome".
• Market Share and Competitive Position — Biome is now estimated to hold about 10% market share in the pharmacy channel, with significant growth potential. Norfolk noted, "we believe Biome Daily is now the leading product in community pharmacy," indicating stron...

Read the full Biome Australia Limited transcript (June 4, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 57 Biome Australia Limited earnings call transcripts on record, spanning January 13, 2020 to June 4, 2026. Based on this history, Biome Australia Limited reports quarterly. The most recent call on file is dated June 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

BIO

Exchange

ASX

Country

AU

Sector

Consumer Staples

Industry

Personal Care Products

Calls on record

57

First call

January 13, 2020

Most recent

June 4, 2026

Reporting cadence

quarterly